SION
Sionna Therapeutics, Inc. Common StockNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$1.86B
P/E Ratio
—
EPS
$-1.86
Beta
—
52W High
$48.45
52W Low
$12.53
50-Day MA
$39.74
200-Day MA
$35.83
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Sionna Therapeutics, Inc. Common Stock
Sionna Therapeutics, Inc. is at the forefront of biotechnology innovation, focusing on the development of advanced therapies for neurodegenerative disorders characterized by protein misfolding, notably Alzheimer's and Parkinson's diseases. Leveraging proprietary technologies and a strong pipeline, Sionna addresses crucial unmet medical needs within this therapeutic area. The company's strategic partnerships and robust commitment to research and development position it as a key player in the biopharmaceutical industry, dedicated to enhancing patient quality of life through transformative neurological advancements.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-98.28M |
| Operating Margin | 0.00% |
| Return on Equity | -26.70% |
| Return on Assets | -18.30% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $6.39 |
| Price-to-Book | 6.44 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $45.15M |
| Float | $16.50M |
| % Insiders | 6.85% |
| % Institutions | 100.59% |
Historical Volatility
HV 10-Day
89.43%
HV 20-Day
71.74%
HV 30-Day
77.41%
HV 60-Day
70.32%
HV Rank
50.0%
Volatility is currently expanding
Analyst Ratings
Consensus ($51.60 target)
1
Strong Buy8
Buy1
Strong SellMore HEALTHCARE Stocks
Data last updated: 5/25/2026